Lower hepatocellular carcinoma surveillance in metabolic dysfunction-associated steatotic liver disease: Impact on treatment eligibility.
Henry-Blake C, Balachandrakumar V, Kassab M, Devonport J, Matthews C, Fox J, Baggus E, Henney A, Stern N, Cuthbertson DJ, Palmer D, Johnson PJ, Hughes DM, Hydes TJ, Cross TJS.
Henry-Blake C, et al. Among authors: balachandrakumar v.
J Gastroenterol Hepatol. 2024 Aug 27. doi: 10.1111/jgh.16727. Online ahead of print.
J Gastroenterol Hepatol. 2024.
PMID: 39191435